| 发明名称 |
ORAL DOSAGE FORMS FOR PROPIVERINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT |
| 摘要 |
<p>By suitable retardation oral pharmaceutical compositions containing propiverine or one or several pharmaceutically acceptable salts thereof in an amount of 4 mg to 60 mg propiverine and having a prolonged release of the active agent are produced. Preferably a blend of active agent and optionally one or more acidic substances having a pKa value of less than 6.65 are provided with a retarding coating or are embedded in a matrix which is then optionally coated with further retarding layers.</p> |
| 申请公布号 |
SI1435915(T1) |
申请公布日期 |
2008.12.31 |
| 申请号 |
SI20020030744T |
申请日期 |
2002.10.08 |
| 申请人 |
APOGEPHA ARZNEIMITTEL GMBH |
发明人 |
GRAMATTE THOMAS;GRUBER PETER;GULDNER PETER;HESCHEL MICHAEL;PAMPERIN DIRK;PLOEN JAN;SCHEITHAUER STEFFEN;WEHNER WOLFGANG |
| 分类号 |
A61K9/10;A61K9/14;A61K9/20;A61K9/22;A61K9/28;A61K9/32;A61K9/48;A61K9/50;A61K9/52;A61K31/445;A61K47/12;A61K47/22;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61K47/42;A61K47/44;A61K47/46 |
主分类号 |
A61K9/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
